Novo Dives On A Key Miss As Its Battle With Lilly Heats Up

Novo Nordisk (NVO) stock plummeted Tuesday on lighter-than-expected June-quarter sales for its new obesity-fighting pill. Analysts are closely watching the developing battle between Novo and Eli Lilly (LLY) which, within the last year, launched pills to help people lose weight. Novo has pulled ahead somewhat after years of trailing Lilly's injections. But during the second quarter, Novo's Wegovy pill generated…

8/08/2026 Among the best stocks in earnings performance, highly rated Eli Lilly is in a buy zone.

8/08/2026 Among the best stocks in earnings performance, highly rated Eli...

Artificial intelligence can help identify and manage cyber threats, but in the hands of bad actors AI also creates new risks. (© Gary Neill)